SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 39 filers reported holding SIO GENE THERAPIES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -94.5% | 20,749 | -89.1% | 0.00% | – |
| Q1 2022 | $128,000 | -82.0% | 190,670 | -65.5% | 0.00% | – |
| Q4 2021 | $713,000 | -16.1% | 552,734 | +41.1% | 0.00% | – |
| Q3 2021 | $850,000 | +217.2% | 391,632 | +298.5% | 0.00% | – |
| Q2 2021 | $268,000 | +20.7% | 98,284 | +15.8% | 0.00% | – |
| Q1 2021 | $222,000 | +138.7% | 84,895 | +152.5% | 0.00% | – |
| Q4 2020 | $93,000 | – | 33,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cladis Investment Advisory, LLC | 1,104,000 | $1,424,000 | 1.31% |
| Prosight Management, LP | 802,180 | $1,035,000 | 0.62% |
| Privium Fund Management B.V. | 1,806,542 | $2,367,000 | 0.47% |
| Rubric Capital Management LP | 3,000,000 | $3,870,000 | 0.18% |
| ACT CAPITAL MANAGEMENT, LLC | 185,000 | $239,000 | 0.17% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $7,629,000 | 0.15% |
| APOGEM CAPITAL LLC | 60,245 | $78,000 | 0.05% |
| Clearline Capital LP | 218,506 | $282,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 166,806 | $215,000 | 0.03% |
| Hudson Bay Capital Management LP | 1,800,000 | $2,322,000 | 0.02% |